Pharmacy Services

Pharmacy Services Residency

Burn Trauma Intensive Care Unit I

 (PGY1 Rotation - Acute Care)

Preceptors:

Maureen Ghanem, PharmD
Ann Marie Prazak, PharmD

Hours: 0700-1530
Pager: 801-339-8082

 

Site and Rotation Description

Burn Trauma ICU (BTICU) is a tertiary referral center that receives burn patients from the Mountain West area (including Utah, Wyoming, Idaho, Colorado, Nevada, and Arizona). The BTICU is a unique experience in that these patients range in age from pediatric to geriatrics with medical acuity ranging from intensive care to rehabilitation. The unit consists of 15 ICU beds, a self-contained OR suite, and an outpatient clinic.

The majority of patients cared for in the BTICU have suffered some sort of thermal injury whether from flame, scald, electrical, or chemical source.  In addition, the BTICU cares for other types of wound-related problems including Stevens-Johnson syndrome, toxic epidermal necrolysis, frostbite, necrotizing fasciitis, gangrene, and other skin disorders which require surgical management.

BTICU is truly a multidisciplinary team consisting of an attending physician, one resident, one intern, occasionally a medical student, nursing, pharmacy, nutrition, physical therapy, respiratory therapy, social work, and child life, who rounds daily on each patient.

The pharmacy resident is responsible for providing comprehensive patient care to all patients in the BTICU. The primary focus of this rotation is patient care and for the resident to become the primary pharmacy contact for the team. The resident is expected to attend daily medical rounds with the BTICU team.

Specific emphasis will be placed on infectious disease issues, altered pharmacokinetics of medication, and metabolic abnormalities that occur in burn patients. Other critical care issues that will be encountered will also be addressed depending on the resident’s experiences prior to this rotation.

Expected progression of resident responsibility on this learning experience:

(Length of time preceptor spends in each of the phases will be customized based upon resident’s abilities and timing of the learning experience during the residency training year)

Day 1:  Preceptor will orient resident to the unit, health care professionals, and workflow.

Week 1: Resident will start by working up at least ½ of the BTICU patients and progressing to work up all patients by the end of the week. Resident must present patients to preceptor daily. Preceptor will attend and participate in team rounds with resident, modeling pharmacist’s role on the health care team. Resident will learn process for documenting pertinent pharmacist-related issues in electronic medical records.

Week 2:  Resident will work up all BTICU patients and bordering patients by the end of the week. Preceptor is still on the unit and available for questions.  Preceptor will continue modeling behaviors. Expect daily patient discussions. Preceptor is to attend team rounds with resident, but encourage and coach the resident to take on more responsibilities as the pharmacist on the team (preceptor sitting at a very short distance away with team able to see preceptor).  Resident will write pertinent notes, with preceptor provided feedback.

Weeks 3-4: Resident is expected to work up all patients and round independently without team able to see preceptor (but possibly sitting somewhere to be able to listen and provide direct, specific feedback). Resident expected to write pertinent notes. Continue to discuss identified problems with preceptor daily. 

Disease States

Common disease states in which the resident may (depending on variable patient population) be expected to gain proficiency through literature review, topic discussion, and/or direct patient care experience including, but not limited to:

  • Shock and related problems (cardiogenic, septic, hypovolemic/hemorrhagic)
  • Renal disorders: AKI, acid-base imbalance, fluid and electrolyte disorders
  • Endocrine disorders: hyperglycemia
  • Psychiatric disorders: ICU psychosis, sleep disturbances, PTSD
  • Infectious Diseases: pneumonia, wound infection; PK/PD
  • Nutrition: Enteral, Parenteral, nutrition considerations
  • Analgesia, sedation, delirium, NMBAs (RSI, ICU paralysis)
  • VTE prophylaxis
  • Stress-ulcer prophylaxis
  • Bowel regimens
  • Necrotizing Fasciitis
  • Fournier’s gangrene
  • TENS/SJS
  • Purpura Fulminans
  • Vaccinations (tetanus/diphtheria, influenza, pneumococcal, pediatric considerations (i.e. catch up schedules)
  • Burn related disorders
    • Basics of burn management
    • Fluid Resuscitation
    • PK/PD
    • Wound Care
    • Topical agents
    • Coverings/dressings
    • Inhalation injury
    • Hypermetabolic syndrome
    • Electrical burns
    • Chemical Burns
    • Frost Bite
    • Pediatric burns

Goals and Objectives

The goals selected to be taught and evaluated during this learning experience include:

  • R2.1 - As appropriate, establish collaborative professional relationships with members of the health care team.
  • R2.4 - Collect and analyze patient information
  • R2.6 - Design evidence-based therapeutic regimens
  • R2.7 - Design evidence-based monitoring plans
  • R2.8 - Recommend or communicate regimens and monitoring plans
  • R2.9 - Implement regimens and monitoring plans
  • R2.10 - Evaluate patients' progress and redesign regimens and monitoring plans

Activities

The activities assigned to this learning experience reflect the activities a pharmacist working in this environment are expected to be able perform.  It is not expected that any particular resident be able to fully perform all of the necessary behaviors and actions of a pharmacist that regularly serves in this unit.  It is expected that the resident demonstrate proactiveness and accountability in patient care.  There is not usually one discrete activity assigned to help achieve an objective and/or goal. 

Residents will be provided with a detailed list of objectives associated with each goal assigned to this rotation. Achievement of the goals of the residency is determined through assessment of your ability to perform the associated objectives.  The table below demonstrates the relationship between the activities the resident will perform on the learning experience and the goals/objectives assigned to the learning experience. 

Goal R2.1 As appropriate, establish collaborative professional relationships with members of the health care team

Obj. R2.1.1

Direct Instruct.
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

The resident will: 1. Actively participate in daily inpatient rounds; 2. Collaborate with BTICU team (i.e. physicians, midlevel practitioners, and nurses) and interact with patients to resolve medication-related issues; 3. Answer drug information questions from the BTICU staff; 4. Become the team’s primary source of information for medication-related matters; 5. Document medication reconciliations and vaccine screenings and discuss pertinent findings with team; and 6. Provide a nursing in-service on a topic recommended by the BTICU nursing staff.

Goal R2.4 Collect and analyze pertinent patient information

Obj R2.4.1

Direct Instruct.
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

Data collection includes labs, system-based organ assessment of all organ systems, drug levels, ventilator settings, nutrition care, antibiotic choice and duration, and all other current medications (analyzed for appropriate dosing based on organ function).  The resident will collect pertinent data from the electronic medical record and document this data on the BTICU standard monitoring form.  Data may initially be found in the transferring, outside facility documents in the patient’s paper chart.  The resident will also perform a bedside assessment of critically ill patients to obtain additional information.  The resident will integrate pertinent patient data during daily pre- and post-rounds discussions with the preceptor and during multidisciplinary rounds with the team.

Obj R2.4.2

Direct Instruct.
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

The resident will review patient profiles multiple times daily to identify the presence of all appropriate therapies and absence of necessary therapies using data collected from electronic medical record (and if applicable, paper chart).  Common problems the resident may be exposed to include medication with no indication; absence of medication necessary for acute or chronic disease state management; inappropriate prescription of medication; inappropriate dosing, dosage form, schedule, or route/method of administration; therapeutic duplication; medication prescribed to which patient is allergic; adverse drug reactions, etc.  The resident will create a general problem list from evaluation of patient data and medication profile.

Obj R2.4.3

Direct Instruct.
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

The resident will use current electronic medical record tools to aggregate data to design a therapeutic plan that summarizes the patient’s health care needs. 

Goal R2.6 Design evidence-based therapeutic regimens

Obj R2.6.1

Direct Instruct.
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

The resident will be exposed to a variety of disease states and relevant literature through topic discussions with the preceptors, independent topic research, journal clubs, and daily patient discussions.  Daily multidisciplinary rounds will expose the resident to discussions related to the social, ethical, and quality of life considerations for each patient when appropriate.  Through synthesis of information obtained in these activities, the resident will identify specific evidence-based therapeutic goals for each patient.

Obj
R2.6.2

Direct Instruct.
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

Based on the identified evidence-based therapeutic goals, the resident will design a medication regimen for each patient using the information outlined in Obj. R2.6.1.  The resident will re-evaluate the appropriateness of this regimen multiple times per day.  The resident will document therapeutic goals and medication regimens in patient-specific progress notes in the electronic medical record.  The resident will also lead discussions with preceptors on a variety of BTICU topics to demonstrate knowledge of literature that can be incorporated into evidence-based therapeutic goals and monitoring plans.  In addition, the resident will present a formal journal club to the preceptors.

Goal R2.7 Design evidence-based monitoring plans

Obj R2.7.1

Direct Instruct.
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

Building from the process described in Goal 2.6, the resident will create evidence-based monitoring plans for BTICU patients, daily and multiple times during the day as the patients’ clinical status changes.  The resident will discuss appropriate monitoring with the BTICU team and document patient-specific progress notes in the electronic medical record.

Goal R2.8 Recommend or communicate regimens and monitoring plans

Obj R2.8.1

Direct Instruct.
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

The resident will participate in multidisciplinary rounds daily. The resident will present and implement the regimens created from earlier review of the patient-specific data, evidence-based literature, and direct discussion with preceptor prior to rounds.  The resident will become proficient in speaking with confidence and efficiency to the medical team.  The resident is also expected to be an excellent listener and collaborate on patient-specific care plans and regimens.  The resident will be a facilitator of patient care and be respectful and personable at all times.  The resident should gain the confidence of their team over the course of the rotation through daily interaction.  The resident will gain perspective of the various ways to solve patient-care issues based on interpretation of patient data, literature, and various experiences from members of the BTICU team.  During normal BTICU rotation hours, the resident will participate in medical emergencies (Rapid response team (RRT) and C-arrest) with the preceptor.

Goal R2.9 Implement regimens and monitoring plans

Obj R2.9.1

Direct Instruct.
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

The resident will implement regimens and monitoring plans according to the organization's policies and procedures.  After proper training and demonstrating competency, the resident will replace electrolytes per the BTICU pharmacist-driven electrolyte protocol. The resident will discuss with the team and ensure that appropriate labs are ordered for monitoring electrolytes with the BTICU pharmacist-driven electrolyte protocol.  The resident will inform the team of the appropriate enoxaparin dose based on the BTICU regression equation (applies to patients with a burn injury only).  The resident will also ensure anti-Xa monitoring for enoxaparin is performed according to the BTICU protocol.

Obj R2.9.2

Direct Instruct.
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

During the medication reconciliation process and when questions arise, the resident will provide education to patients and caregivers on medication therapy, adverse effects, compliance, appropriate use, handling, and medication administration.

Goal R2.10 Evaluate patients' progress and redesign regimens and monitoring plans

Obj R2.10.1

Direct Instruction
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

The resident will re-evaluate the patient’s electronic medical record to assess degrees and trends of organ dysfunction and reassess the appropriateness of the medication regimen multiple times daily to determine any necessary changes in the therapeutic monitoring plan.  The resident will communicate effectively with the team regarding any necessary modification of the regimen.

Obj R2.10.2

Direct Instruction
Coaching
Facilitating
Modeling

Teach
Observe
Evaluate
Facilitate

The resident will re-design previous plans and regimens throughout the day.  The resident will communicate pertinent items to the team and take responsibility for changing plans/regimens in a timely manner.

The resident may complete a small project while on rotation in the BTICU. The choice of project will depend on the interests of the resident and the needs of the BTICU.

Preceptor Interaction  (daily)

*Note times are provided as an example and may vary from day to day*
0700-0900 Preceptor available while resident and preceptor work up patients
0900-1000 Pre-rounds with resident (assuming rounds start at 1000)
1000-1530 Daily rounds with resident and team (and preceptor until resident and preceptor comfortable with resident rounding independently)
1000-1530 Preceptor available for topic discussions, reviewing progress notes, patient updates, etc.

Communication:

  1. Daily scheduled meeting times: Residents to prioritize questions and problems to discuss during scheduled meeting times as listed above (pre-rounds best time to maximize efficiency in implementing patient care during rounds).
  2. E-mail: Residents are expected to read e-mails at the beginning, middle, and end of each day at a minimum for ongoing communication. This is appropriate for routine, non-urgent questions, and problems; however, most communication is in person verbally since preceptors are always available and usually on the unit. 
  3. Office extension: Appropriate for urgent questions pertaining to patient care.
  4. Pager: Residents will carry personal pager and be available to be contacted by preceptor.  Preceptor will carry unit pager and be primary mode of contact if pharmacist is not on the unit.
  5. Personal phone number: Provided to resident at time of learning experience for issues that arise and the preceptor is not reachable by other means.

Evaluation Strategy

Residents will be provided with verbal feedback on a frequent (at least every other day, possibly several times daily) basis. ResiTrak will be used for documentation of scheduled evaluations. For all evaluations completed in ResiTrak, the resident and the preceptor will independently complete the assigned evaluation and save as draft.  The resident and the preceptor will then compare and discuss the evaluations.  This discussion will provide feedback both on performance of the activities and the accuracy of the resident’s self-assessment skills.  Evaluations will be signed in ResiTrak following this discussion.

What type of evaluation

Who

When

Midpoint

Preceptor, Resident

End of week 2

Summative

Preceptor

End of learning experience

Summative Self-evaluation

Resident

End of learning experience

Preceptor, Learning Experience Evaluations

Resident

End of learning experience